Research ArticleResearchWorkflowQuality Improvement

Tele-ICU rounds increased breathing trials and shortened weaning time without improving weaning success

Critical care (London, England) (PubMed)Aug 7, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A secondary analysis of a stepped-wedge cluster-randomized ICU trial found that daily telemedicine rounds by an intensivist and ICU nurse increased spontaneous breathing-trial use and shortened time from the first trial to successful weaning, but did not improve the overall weaning-success rate.

What NurseJet pulled from the source

Among 308 ventilated patients with at least one spontaneous breathing trial, trials occurred on 51% of intervention patient-days versus 27% of control patient-days. Adjusted analysis associated the intervention with shorter time to successful weaning, while weaning classification and success did not differ significantly.

Why this matters for nurses

ICU nurses identify readiness cues, coordinate spontaneous breathing trials, monitor tolerance, and communicate barriers during weaning. The study suggests structured remote interprofessional review can improve process reliability, while the absence of a clear success-rate benefit keeps attention on patient selection and local workflow.

Bedside takeaway

Make daily weaning readiness and breathing-trial plans visible, documented, reassessed, and easy for bedside and tele-ICU teams to coordinate.

How This Applies in Practice

Use this when: Participating in daily ventilator-weaning review for an ICU patient within an approved bedside or tele-ICU pathway.

On your shift

Confirm that readiness screening, sedation targets, mobility, secretion management, and the spontaneous breathing-trial plan are addressed during rounds.
Document trial timing, tolerance criteria, reasons for deferral or failure, and the next reassessment so remote and bedside teams share one plan.
Escalate respiratory, neurological, or hemodynamic instability immediately rather than waiting for the next scheduled telemedicine review.

Keep in mind: The study does not establish one weaning schedule or tele-ICU model for every patient or unit. Follow the critical-care protocol, facility policy, and provider orders.

Key takeaways

The analysis included 308 patients from ten ICU clusters who received invasive ventilation for at least two days and at least one spontaneous breathing trial.
Spontaneous breathing trials occurred on 51% of intervention patient-days and 27% of control patient-days.
Weaning success was 36% with the intervention and 28% under the control condition, a nonsignificant difference.
The adjusted model associated telemedicine support with a shorter interval from the first breathing trial to successful weaning.

Practice implications

During an approved weaning pathway, document daily readiness screening, the planned breathing trial, tolerance findings, sedation and mobility barriers, and the next reassessment. Use tele-ICU input to clarify the plan without delaying bedside escalation for instability.

Limitations & cautions

This was a secondary analysis of one metropolitan stepped-wedge trial, with 55 patients in the control condition and 253 in the intervention condition. It included only patients ventilated for at least two days who had at least one breathing trial, and the intervention bundled telemedicine rounding around several ICU quality indicators, limiting causal attribution and generalizability.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Critical care (London, England) (PubMed)

Critical care (London, England) (PubMed). The impact of an intensive care telemedicine program on weaning from invasive ventilation: a secondary analysis of the ERIC trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42568095/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Western journal of nursing research (PubMed)Oct 15, 2026Systematic Review

A systematic review and meta-analysis of 38 studies including 19,033 patients identified clinical severity scales—specifically Modified Fisher grade and Fisher grade—and hemodynamic status as the strongest predictors of cerebral vasospasm following subarachnoid hemorrhage.

Emergency ICUAI summaryReview source

Systematic ReviewResearchQuality ImprovementAI summary · original source linked below

Cerebral vasospasm is a severe complication of aneurysmal subarachnoid hemorrhage (SAH) that frequently precipitates delayed cerebral ischemia and increases patient mortality. To clarify clinical predictors and inform intensive care nursing assessments, investigators conducted a systematic review and meta-analysis across eight databases through August 2024, evaluating study quality with the Joanna Briggs Institute checklist and Risk of Bias 2.0 tool. Across 38 included studies (27 in the meta-analysis) encompassing 19,033 patients, clinical severity metrics showed the strongest association with cerebral vasospasm: Modified Fisher grade (odds ratio [OR] 2.88; 95% CI, 2.04–4.07), Fisher grade (OR 2.27; 95% CI, 1.91–2.69), and hemodynamic status (OR 2.56; 95% CI, 1.17–5.59). Aneurysm-related characteristics and comorbid conditions were also linked to increased vasospasm risk, whereas clinical biomarkers and inflammatory markers demonstrated comparatively smaller effect sizes.

Key takeaways

Systematic review and meta-analysis synthesized 38 studies (27 in meta-analysis) encompassing 19,033 patients after subarachnoid hemorrhage.
Radiographic and clinical severity scales showed the strongest association with cerebral vasospasm: Modified Fisher grade (OR 2.88; 95% CI, 2.04–4.07) and Fisher grade (OR 2.27; 95% CI, 1.91–2.69).
Hemodynamic instability was strongly associated with vasospasm risk (OR 2.56; 95% CI, 1.17–5.59).
Aneurysm features and comorbidities also increased risk, while clinical biomarkers and inflammatory markers demonstrated smaller effect sizes.

Why this matters on shift

Neurocritical care nurses are the first line of defense in detecting subtle neurological deterioration and hemodynamic shifts in patients hospitalized for subarachnoid hemorrhage. Understanding that initial Fisher grade and hemodynamic status carry the highest statistical odds for vasospasm reinforces rigorous serial neurological scoring and strict blood pressure monitoring during the peak vasospasm window.

Bedside takeaway

In a meta-analysis of 19,033 SAH patients, Modified Fisher grade (OR 2.88), Fisher grade (OR 2.27), and hemodynamic status (OR 2.56) were the strongest predictors of cerebral vasospasm.

Nursing implications

Identify admission Fisher or Modified Fisher scores during shift handoff, maintain strict hemodynamic parameters per provider orders, and immediately escalate focal neurological deficits, altered sensorium, or transcranial Doppler velocity increases.

Limitations & cautions

Synthesized observational studies with heterogeneous definitions and reporting standards; meta-analysis reflects statistical associations rather than prospective causal prediction models; abstract does not detail specific individual biomarker cutoff values.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Western journal of nursing research (PubMed). Key Predictors of Cerebral Vasospasm Following Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Clinical research in cardiology : official journal of the German Cardiac Society (PubMed)Sep 28, 2026Research Article

A prespecified sex-specific secondary analysis of the PUSH-AHF trial in 310 patients found natriuresis-guided diuretic therapy increased 24-hour sodium excretion and reduced 180-day mortality or heart failure readmission in men, but not in women.

Telemetry ICUAI summaryReview source

Research ArticleResearchMedication SafetyAI summary · original source linked below

Natriuresis-guided loop diuretic titration uses spot urinary sodium measurements to tailor decongestive therapy in acute heart failure (AHF). In this sex-specific analysis of the randomized PUSH-AHF trial, investigators evaluated 310 patients (45% women) assigned to natriuresis-guided therapy versus standard of care. In men, natriuresis-guided therapy produced significantly greater mean 24-hour total natriuresis compared with standard care (443 vs 354 mmol, p = 0.004), whereas women showed no significant difference between treatment arms (357 vs 336 mmol, p = 0.533; adjusted p-interaction = 0.276). Notably, the median 24-hour natriuretic response per milligram of loop diuretic (bumetanide equivalents) was significantly lower in women receiving natriuresis-guided therapy than standard care (23 vs 52 mmol/mg, p = 0.001), while no difference was observed in men (38 vs 45 mmol/mg, p = 0.337; adjusted p-interaction = 0.009). Clinically, natriuresis guidance was associated with a 49% lower risk of 180-day all-cause mortality or HF rehospitalization in men (adjusted HR 0.51; 95% CI, 0.30–0.86; p = 0.011), but showed no benefit in women (adjusted HR 1.40; 95% CI, 0.67–2.91; p = 0.368; adjusted p-interaction = 0.026).

Key takeaways

Sex-specific analysis of the PUSH-AHF randomized trial evaluated 310 patients (45% women) with acute heart failure.
In men, natriuresis-guided therapy increased 24-hour urinary sodium excretion (443 vs 354 mmol, p = 0.004) and reduced 180-day mortality/rehospitalization by 49% (adjusted HR 0.51, p = 0.011).
In women, natriuresis guidance did not increase total natriuresis (357 vs 336 mmol, p = 0.533) or improve 180-day clinical outcomes (adjusted HR 1.40, p = 0.368; p-interaction = 0.026).
Women in the guided arm exhibited a blunted natriuretic response per milligram of loop diuretic (23 vs 52 mmol/mg bumetanide, p = 0.001).

Why this matters on shift

Cardiology and telemetry nurses frequently manage intensive loop diuretic infusions and collect spot urinary sodium samples during acute decompensated heart failure admissions. These findings demonstrate that diuretic responsiveness and natriuresis-guided protocols may operate differently by biological sex, warning clinicians that intensifying diuretic doses based solely on spot sodium targets may not yield uniform decongestive or prognostic benefits across all patient groups.

Bedside takeaway

In the PUSH-AHF trial (310 patients), natriuresis-guided diuretic therapy reduced 180-day mortality/readmission in men (aHR 0.51) but showed no benefit in women (aHR 1.40; p-interaction=0.026).

Nursing implications

Collect urine samples for spot sodium strictly at ordered intervals during acute decongestion, maintain accurate intake/output records, monitor serum electrolytes and renal function closely during diuretic uptitration, and recognize that blunted urinary sodium output in female patients may reflect altered pharmacodynamics rather than simple noncompliance with fluid restrictions.

Limitations & cautions

Post-hoc subgroup analysis of a randomized trial with limited sample size (n = 310, including 139 women); findings are hypothesis-generating and require prospective validation in sex-stratified clinical trials before modifying clinical guidelines.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Clinical research in cardiology : official journal of the German Cardiac Society (PubMed). Effects of natriuresis-guided diuretic therapy in men and women with acute heart failure: insights from PUSH-AHF.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Worldviews on evidence-based nursing (PubMed)Oct 1, 2026Systematic Review

A systematic review and meta-analysis of hospital sensor-based fall prevention systems found no significant overall reduction in falls or injuries, but machine-learning systems and mandatory implementation significantly lowered fall rates.

Med-Surg GeriatricsAI summaryReview source

Systematic ReviewResearchQuality ImprovementWorkflowAI summary · original source linked below

Hospital falls remain a pervasive cause of patient injury, extended length of stay, and nursing alarm fatigue. This systematic review and meta-analysis synthesized evidence from 16 interventional studies (seven pooled in meta-analysis) across MEDLINE, Embase, CINAHL, CENTRAL, and Web of Science evaluating sensor-based fall prevention technologies in hospital units. Using random-effects models with the Paule-Mandel estimator and Hartung-Knapp-Sidik-Jonkman adjustment, sensor systems overall demonstrated no statistically significant reduction in fall rates (incidence rate ratio [IRR] 0.77; 95% CI 0.38–1.58; I² = 92%), number of fallers (odds ratio 1.24; 95% CI 0.76–2.02; I² = 73%), or fall-related injuries (IRR 0.98; 95% CI 0.81–1.18; I² = 0%). However, subgroup analysis revealed that advanced machine learning-based sensor systems significantly reduced fall rates (IRR 0.50; 95% CI 0.32–0.79), whereas conventional rule-based sensors showed no effect. Mandatory unit-wide implementation was also associated with significantly reduced fall rates (IRR 0.51; 95% CI 0.37–0.70). Overall GRADE evidence certainty ranged from very low to low.

Key takeaways

Meta-analysis of 16 hospital studies found sensor-based fall systems overall did not significantly reduce fall rates (IRR 0.77) or injuries (IRR 0.98).
Machine learning-based sensor systems significantly cut inpatient fall rates by 50% (IRR 0.50, 95% CI 0.32–0.79).
Traditional rule-based pressure sensors showed no significant benefit on fall incidence.
Mandatory unit-wide sensor implementation was associated with a significant fall rate reduction (IRR 0.51, 95% CI 0.37–0.70), but not fewer fallers.

Why this matters on shift

Hospital bed and chair alarms are ubiquitous on med-surg and geriatric units, but frequently generate high false-alarm burdens and alert fatigue without clearly preventing patient harm. Demonstrating that conventional sensors fail to reduce falls while AI/machine-learning systems and unit-wide compliance halve fall rates informs hospital technology investments and nursing safety protocols.

Bedside takeaway

A meta-analysis found hospital sensor alarms overall did not reduce falls (IRR 0.77) or injuries (IRR 0.98), though machine-learning sensors significantly reduced fall rates by 50% (IRR 0.50).

Nursing implications

Do not rely on standard pressure sensor alarms as standalone fall prevention; pair technology with intentional rounding, assisted toileting, and environmental safety checks. When modern predictive or machine-learning sensors are deployed, adhere strictly to unit operational protocols to realize preventative benefits.

Limitations & cautions

High statistical heterogeneity among included trials (I² up to 92%); only seven studies eligible for statistical pooling; overall certainty of evidence rated very low to low under GRADE criteria.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Worldviews on evidence-based nursing (PubMed). Effectiveness of Sensor-Based Fall Prevention Systems in Hospitals: A Systematic Review and Meta-Analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Meta-analysis of 19,033 SAH patients identifies clinical severity and hemodynamics as top predictors of cerebral vasospasm

PUSH-AHF trial analysis finds natriuresis-guided diuretic therapy reduces 180-day events in men but not women with acute heart failure

Meta-analysis of hospital sensor fall systems finds no overall fall reduction, but machine-learning sensors cut rates by 50%